AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 9515521
Drug: Single-dose regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose regimen of ticarcillin 3.0 g/clavulanate 0.1 g (Timentin)
Trial: 9515521
Drug: Multiple-dose regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple-dose regimen of ticarcillin 3.0 g/clavulanate 0.1 g (Timentin)
Trial: 8695969
Drug: Conjugated equine
RxNorm normalized name: Conjugated equine estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated equine estrogens 0.30 mg/day plus oral ipriflavone 200 mg tris in die at meals (group C)
Trial: 8695969
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus conjugated equine estrogens 0.30 mg/day (group B)
Trial: 2085984
Drug: Amoxycillin/clavulanate (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxycillin/clavulanate (5 days treatment)
Trial: 16941068
Drug: Fosfomycin trometamol
RxNorm normalized name: trometamol
DrugBank: Tromethamine (DB03754)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fosfomycin trometamol (single dose)
Trial: 30472886
Drug: Positive perception
RxNorm normalized name: Herceptin
DrugBank: Trastuzumab (DB00072)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Positive perception of insulin treatment
Trial: 30472886
Drug: Only using
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Only using insulin when alone in public places
Trial: 27101422
Drug: Ferric maltol
RxNorm normalized name: Ferric Maltol
DrugBank: Ferric maltol (DB15598)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Ferric maltol 30 mg twice daily
Trial: 27101422
Drug: Ferric maltol
RxNorm normalized name: Ferric Maltol
DrugBank: Ferric maltol (DB15598)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Ferric maltol 60 mg twice daily
Trial: 27101422
Drug: Ferric maltol
RxNorm normalized name: Ferric Maltol
DrugBank: Ferric maltol (DB15598)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Ferric maltol 90 mg twice daily
Trial: 21985332
Drug: Couple's risk
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Couple's risk reduction intervention combined with evidence-based medication adherence intervention
Trial: 18840576
Drug: Warm priming
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warm priming solution at 36 degrees C
Trial: 18840576
Drug: Cold priming
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cold priming solution at 20 degrees C
Trial: 17062362
Drug: Deoxyribonucleotidum in
RxNorm normalized name: Adenine Deoxyribonucleoside
DrugBank: Adenosine (DB00640)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Deoxyribonucleotidum in addition to routine treatment
Trial: 10896369
Drug: Experimental agent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental agent
Trial: 2014035
Drug: Lidoflazine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidoflazine (1 mg/kg loading dose, followed by 0.25 mg/kg at 8 and 16 hours after resuscitation)
Trial: 7152766
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group maintained normal daily activities including a 1 day per week physical education class for 8 months
Trial: 22325113
Drug: Doxycycline (DOX)
RxNorm normalized name: Doxycycline
DrugBank: Doxycycline (DB00254)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Doxycycline (DOX) 100 mg twice daily for 5 days
Trial: 8781634
Drug: Omeprazole 40
RxNorm normalized name: omeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 40 mg om for 2-4 weeks followed by maintenance omeprazole 20 mg om for one year
Trial: 8781634
Drug: Short course
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short course therapy with omeprazole only, followed by placebo
Trial: 2187071
Drug: 600 mg/day
RxNorm normalized name: Rebetron, single dose 600 mg/day oral and injectable kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg/day of zidovudine for 18 weeks
Trial: 2187071
Drug: 900 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 900 mg/day of zidovudine
Trial: 2187071
Drug: 1,200 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,200 mg/day of zidovudine
Trial: 30606815
Drug: Terlipressin (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terlipressin (2 mg bolus + 0.5-1 mg/h) + 80% hepatectomy
Trial: 12855342
Drug: Tramadol (275.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol (275.5 mg/day average after dose adaptation)
Trial: 10475311
Drug: Epidural morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural morphine for preemptive analgesia in limb surgery
Trial: 10475311
Drug: Epidural morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural morphine for preemptive analgesia in mastectomy
Trial: 10475311
Drug: Epidural morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural morphine for preemptive analgesia in gastrectomy
Trial: 10475311
Drug: Epidural morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural morphine for preemptive analgesia in hysterectomy
Trial: 10475311
Drug: Epidural morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural morphine for preemptive analgesia in herniorrhaphy
Trial: 10475311
Drug: Epidural morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural morphine for preemptive analgesia in appendectomy
Trial: 10475311
Drug: Epidural morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural morphine for preemptive analgesia in hemiorrhaphy
Trial: 8595171
Drug: Fadrozole hydrochloride
RxNorm normalized name: Chlorpromazine Hydrochloride
DrugBank: Fadrozole (DB16832)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fadrozole hydrochloride 0.5 mg orally b.d.
Trial: 8595171
Drug: Fadrozole hydrochloride
RxNorm normalized name: Chlorpromazine Hydrochloride
DrugBank: Fadrozole (DB16832)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fadrozole hydrochloride 1.0 mg orally b.d.
Trial: 8595171
Drug: Fadrozole hydrochloride
RxNorm normalized name: Chlorpromazine Hydrochloride
DrugBank: Fadrozole (DB16832)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fadrozole hydrochloride 2.0 mg orally b.d.
Trial: 2015175
Drug: Ibuprofen liquid
RxNorm normalized name: ibuprofen Oral Liquid Product
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen liquid in a gelatin capsule
Trial: 2015175
Drug: Ibuprofen tablets
RxNorm normalized name: Ibuprofen Tablets
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen tablets (Nurofen)
Trial: 6799415
Drug: Penicillin V,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Penicillin V, Amoxicillin, Ampicillin, Erythromycin estolate, Erythromycin ethylsuccinate, Trimethoprim-sulfamethoxazole, Cefaclor
Trial: 25666004
Drug: 25 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 μg of intravaginal misoprostol
Trial: 25666004
Drug: 50 μg
RxNorm normalized name: penicillin G 50 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 μg of intravaginal misoprostol
Trial: 15219299
Drug: Nebulized magnesium
RxNorm normalized name: Hydra-Neb
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulized magnesium sulfate plus albuterol
Trial: 15219299
Drug: Nebulized albuterol
RxNorm normalized name: Albuterol
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulized albuterol plus saline
Trial: 9879606
Drug: Daily regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily regimen of 3 MU for patients with unmodified AMT levels
Trial: 9879606
Drug: 24-month treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24-month treatment vs 12-month treatment
Trial: 2481532
Drug: Heparin (additional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin (additional administration)
Trial: 810198
Drug: Thyrotrophin-releasing hormone
RxNorm normalized name: thyrotropin-releasing hormone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thyrotrophin-releasing hormone (TRH) 600 mug, given daily for four days
Trial: 810198
Drug: Placebo, given
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo, given daily for four days
Trial: 28549430
Drug: Intra-articular injection
RxNorm normalized name: PHOSPHORUS P-32 5 mCi in 1 mL INTRA-ARTICULAR INJECTION, SUSPENSION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular injection of reticulated hyaluronic acid (KARTILAGE® CROSS, 16 mg/ml, one single injection of 2.2 mL)
Trial: 28549430
Drug: Intra-articular injection
RxNorm normalized name: PHOSPHORUS P-32 5 mCi in 1 mL INTRA-ARTICULAR INJECTION, SUSPENSION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular injection of reticulated hyaluronic acid (KARTILAGE® CROSS)
Trial: 23707085
Drug: Dexmedetomidine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine infusion (0.2 μg/kg/h for 30 minutes before the procedure, followed by 0.4 μg/kg/h for 6 hours after the procedure)
Trial: 23707085
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (volume‐matched normal saline solution)
Trial: 21718523
Drug: Guided Internet-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guided Internet-based cognitive-behavioral treatment for depression
Trial: 15970035
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of garlic paste for 14 days
Trial: 15970035
Drug: Clotrimazole solution
RxNorm normalized name: Clotrimazole
DrugBank: Clotrimazole (DB00257)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clotrimazole solution
Trial: 12520172
Drug: Regular tablets
DrugBank: Sodium fluorophosphate (DB09484)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular tablets
Trial: 10754455
Drug: VML 295
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VML 295 at 200 mg twice daily
Trial: 10754455
Drug: VML 295
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VML 295 at 200 mg once daily
Trial: 8862229
Drug: Carvedilol (C)
RxNorm normalized name: Carvedilol
DrugBank: Carvedilol (DB01136)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carvedilol (C) (25 mg)
Trial: 1636469
Drug: Smoking cessation
RxNorm normalized name: Zyban 150 MG Smoking Cessation 12 HR Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Smoking cessation treatment program
Trial: 24925350
Drug: H. pylori
RxNorm normalized name: H. PYLORI AGENTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H. pylori treatment with amoxicillin‐omeprazole
Trial: 20333738
Drug: BoNT/A treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BoNT/A treatment after diode laser hair removal
Trial: 20333738
Drug: BoNT/A treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BoNT/A treatment without diode laser hair removal
Trial: 20117244
Drug: Continuous therapy
RxNorm normalized name: varenicline
DrugBank: Varenicline (DB01273)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuous therapy with certolizumab pegol (400 mg every 4 weeks)
Trial: 20117244
Drug: Drug-interruption (placebo)
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Drug-interruption (placebo)
Trial: 10578479
Drug: Soy beverage
RxNorm normalized name: soy acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy beverage containing 20 g of protein and 38 mg of total isoflavones
Trial: 6313596
Drug: Acyclovir (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acyclovir (500 mg/m2/dose three times daily for 7 days)
Trial: 6313596
Drug: Vidarabine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vidarabine (10 mg/kg/day for 5 days)
Trial: 6313596
Drug: Acyclovir (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acyclovir (500 mg/m2/dose infused over one hour three times daily for 7 days)
Trial: 24552979
Drug: Monthly minodronate
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Monthly minodronate (50 mg)
Trial: 24552979
Drug: Weekly alendronate
RxNorm normalized name: alendronate
DrugBank: Alendronic acid (DB00630)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Weekly alendronate (35 mg)
Trial: 22377800
Drug: Oral progesterone
RxNorm normalized name: Progesterone
DrugBank: Progesterone (DB00396)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral progesterone administration (25-50 mg at 16:00 and 20:00 h)
Trial: 17255295
Drug: Cytoreductive nephrectomy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cytoreductive nephrectomy before cytokine therapy
Trial: 17255295
Drug: Targeted agents
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Targeted agents for advanced renal cell carcinoma
Trial: 15356779
Drug: Ciprofloxacin 250
RxNorm normalized name: ciprofloxacin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin 250 mg twice daily for 14 days
Trial: 15194131
Drug: Ciprofloxacin 250
RxNorm normalized name: ciprofloxacin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin 250 mg twice daily for 3 days
Trial: 31468249
Drug: CBT (Cognitive-Behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CBT (Cognitive-Behavioral Therapy)
Trial: 31468249
Drug: COPE-CBT (Cognitive-Behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: COPE-CBT (Cognitive-Behavioral Therapy)
Trial: 18838477
Drug: Imatinib 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imatinib 600 mg daily
Trial: 18001721
Drug: Tibolone (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tibolone (2.5 mg/d orally; group A)
Trial: 18001721
Drug: Placebo (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (1 tablet per d; group B)
Trial: 12579104
Drug: Magnesium sulfate
RxNorm normalized name: Magnesium Sulfate
DrugBank: Magnesium (DB14513)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Magnesium sulfate (24.34 mEq or 3 g in 100 mL saline solution administered over 2 hours preoperatively, perioperatively, and on postoperative days 0, 1, 2, and 3)
Trial: 12579104
Drug: Saline solution
RxNorm normalized name: Unisol 4 Saline Solution
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline solution (100 mL administered according to the same schedule as treatment group)
Trial: 9523374
Drug: Low-dose oral
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose oral baclofen administered for 14 days
Trial: 793842
Drug: Sodium valproate,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium valproate, 400 mg
Trial: 793842
Drug: Phenobarbital, 60
RxNorm normalized name: Phenobarbital, 60 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenobarbital, 60 mg
Trial: 793842
Drug: Sodium valproate
RxNorm normalized name: sodium valproate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium valproate and phenobarbital in combination
Trial: 26843724
Drug: 100 ml
RxNorm normalized name: PVC IV Bag 100 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 ml of instant coffee divided into three portions right after removing the nasogastric tube, first postoperative day
Trial: 26843724
Drug: 100 ml
RxNorm normalized name: PVC IV Bag 100 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 ml of tea
Trial: 26843724
Drug: 100 ml
RxNorm normalized name: PVC IV Bag 100 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 ml of instant coffee
Trial: 24075659
Drug: Moderate force
RxNorm normalized name: Clean Force
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Moderate force (50-g force applied bilaterally to the first premolars for 1, 4, 8, or 12 weeks)
Trial: 24075659
Drug: Severe force
RxNorm normalized name: Clean Force
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Severe force (300-g force applied bilaterally to the first premolars for 1, 4, 8, or 12 weeks)
Trial: 16460338
Drug: Ropivacaine alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine alone (0.75% ropivacaine, 1.8 ml)
Trial: 16460338
Drug: Ropivacaine +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine + epinephrine (1.8 ml)
Trial: 15690112
Drug: Preparation stage
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preparation stage of change
Trial: 9032501
Drug: 3 month
RxNorm normalized name: TABLET, DOSE PACK, 3 MONTHS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 month rehabilitation programme including drug treatment
Trial: 9032501
Drug: Control period
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control period of drug treatment only
Trial: 8320490
Drug: Intravenous deferoxamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous deferoxamine (DFO) at 180 mg/kg/day
Trial: 8320490
Drug: Intravenous deferoxamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous deferoxamine (DFO) at 150 mg/kg/day for 3 months
Trial: 26004980
Drug: Pharmacological treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacological treatment adherence at six months assessment
Trial: 26004980
Drug: Pharmacological treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacological treatment adherence at twelve months assessment
Trial: 17893603
Drug: Group C:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group C: basiliximab, TAC (0.05 mg/kg twice daily) plus MMF (1 g twice daily)
Trial: 17893603
Drug: Group A:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group A: Thymoglobulin, CsA (4 mg/kg twice daily) plus azathioprine (1.5 mg/kg once daily)
Trial: 17893603
Drug: Group B:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group B: basiliximab, CsA (2 mg/kg twice daily) plus MMF (1 g twice daily)
Trial: 8067552
Drug: ondansetron 0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ondansetron 0.15 mg/kg intravenously
Trial: 8067552
Drug: metoclopramide 0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: metoclopramide 0.25 mg/kg intravenously
Trial: 8067552
Drug: normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: normal saline 0.3 mL/kg (Control)
Trial: 3054622
Drug: Maprotiline (116.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maprotiline (116.75 mg/day)
Trial: 3054622
Drug: Chlorimipramine (116.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorimipramine (116.25 mg/day)
Trial: 31155764
Drug: Standard care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard care with prophylactic protocol and monitoring (enzyme declogging kits administered every 7 days for 4 weeks)
Trial: 28609319
Drug: methylprednisolone 20
RxNorm normalized name: methylprednisolone 2000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: methylprednisolone 20 mg
Trial: 28609319
Drug: methylprednisolone 40
RxNorm normalized name: methylprednisolone 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: methylprednisolone 40 mg
Trial: 28609319
Drug: triamcinolone acetonide
RxNorm normalized name: Triamcinolone Acetonide
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: triamcinolone acetonide 20 mg
Trial: 28609319
Drug: triamcinolone acetonide
RxNorm normalized name: Triamcinolone Acetonide
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: triamcinolone acetonide 40 mg
Trial: 28739492
Drug: Citalopram (30±5.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram (30±5.8 mg/d)
Trial: 28739492
Drug: Quetiapine (94.0±40.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quetiapine (94.0±40.4 mg/d)
Trial: 28739492
Drug: Olanzapine (5.2±1.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine (5.2±1.6 mg/d)
Trial: 24038103
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment (specifics not provided)
Trial: 24038103
Drug: No active
RxNorm normalized name: Aveeno Active Naturals
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No active treatment (implied control group)
Trial: 16565560
Drug: Granulocyte colony-stimulating
RxNorm normalized name: Granulocyte colony-stimulating factor lenograstim
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granulocyte colony-stimulating factor (G-CSF) treatment, subcutaneously injected once a day for 10 days at a low dose.
Trial: 16565560
Drug: Non-G-CSF control
RxNorm normalized name: G-CSF
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-G-CSF control group.
Trial: 12603186
Drug: Fluticasone 100
RxNorm normalized name: FLUTICASONE 100MCG/BLSTR PO INH ROTADISK
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluticasone 100 microg daily
Trial: 12603186
Drug: Fluticasone 1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluticasone 1000 microg daily
Trial: 12603186
Drug: Fluticasone 2000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluticasone 2000 microg daily
Trial: 10926069
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg morphine intra‐articularly (group 1)
Trial: 10926069
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg morphine + 150 microg clonidine intra‐articularly (group 3)
Trial: 24140033
Drug: Prolutex (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prolutex (25 mg subcutaneously daily)
Trial: 24140033
Drug: Crinone (90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crinone (90 mg 8% gel daily)
Trial: 22987458
Drug: Hyperbaric oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperbaric oxygen therapy (HBOT) at 153 kPa (1.5 ATA)